MedTrace Logo

Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure

NCT03294863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-01-27

No results posted yet for this study

Summary

The purpose of this study is to determine whether the use of the embrace device after repair of linear cutaneous surgery wounds improves scar cosmesis.

Conditions

  • Linear Cutaneous Wound

Interventions

DEVICE

Embrace Scar Therapy Device

16x5-cm silicone elastomeric dressing that adheres to the skin using a pressure-sensitive silicone adhesive.

OTHER

Standard of Care

Without the embrace Scar Therapy Device

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Daniel B Eisen, MD · UC Davis

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2021-12-01
Completion
2025-12-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03294863 on ClinicalTrials.gov